Please try another search
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Name | Age | Since | Title |
---|---|---|---|
Charles L. Rice | 59 | 2020 | Independent Director |
Jean Buteau | - | 2022 | Chairman of Scientific Advisory Board |
Andrew Albert Kucharchuk | 43 | 2020 | Vice Chairman, COO, Acting CFO & Chief Business Officer |
Andrew G. Reaume | - | 2021 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review